Best price 85721-33-1 with fast delivery CAS NO.85721-33-1
- FOB Price: USD: 55.00-70.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
99%(1-10)Kilogram99%(10-100)Kilogram
- Product Details
Keywords
- 85721-33-1
- Ciprofloxacin
- The third-generation quinolone antibiotics have broad antibacterial spectrum, strong and rapid bactericidal power
Quick Details
- ProName: Best price 85721-33-1 with fast delive...
- CasNo: 85721-33-1
- Molecular Formula: C17H18FN3O3
- Appearance: white powder
- Application: Suitable for respiratory infections, u...
- DeliveryTime: Shipped in 15 days after payment
- PackAge: according to customers' requirements
- Port: China main port
- ProductionCapacity: 10000 Metric Ton/Month
- Purity: 99%
- Storage: Store at 0-5°C
- Transportation: Air, sea, land transport
- LimitNum: 1 Kilogram
- Moisture Content: 0.01%
- Impurity: 0.5%MAX
Superiority
Our company has been in existence for 10 years since its establishment. We have our own unique team. The company integrates independent research and development, production and sales. We have established famous brands at home and abroad. At present, our customers have spread all over the world, we have rich Transportation experience, we aim to serve customers, to help customers, solve problems for customers. Look forward to working with you!
Details
Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent.
Application
Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Diseases Society of America for the treatment of community-acquired abdominal infections in adults.It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis,certain types of endocarditis, certain skin infections, and prosthetic joint infections.